Full-Plus CDC diabetes prevention program
status awarded to Newtopia for development of sustainable healthy
habits and improved disease prevention biometrics among
participants
TORONTO, Sept. 20,
2022 /CNW/ - Newtopia Inc. ("Newtopia" or the
"Company") (TSXV: NEWU) (OTCQB: NEWUF), a tech-enabled whole health
platform creating sustainable habits that prevent, slow, and
reverse chronic disease, today announced that its alternative
diabetes prevention program has received the highest Full-Plus
recognition from the Centers for Disease Control and Prevention
(CDC).
The CDC reserves Full-Plus designation for diabetes prevention
programs that effectively deliver quality, evidence-based
components that meet all CDC recognition standards as well as
additional engagement and retention thresholds. This achievement
acknowledges the sustained success of Newtopia's novel approach to
preventing, slowing and reversing type 2 diabetes through habit
change and the invaluable contribution to addressing the disease
nationally.
"With 96 million American adults having prediabetes,
resulting in $327 billion in medical
costs, the need to successfully address type 2 diabetes with proven
engagement and outcomes is immense," said Jeff Ruby, Founder
and Chief Executive Officer of Newtopia. "To have the CDC
award Newtopia with its highest designation of Full-Plus and
specifically note that 'Newtopia is turning the tide in the
fight against the epidemic of type 2 diabetes' is truly a
testament to our differentiated approach to create sustainable
habit change among participants. I could not be prouder of
our team for achieving this designation and congratulate our
remarkable employer and health plan clients for offering the very
best disease prevention to employees and members."
Newtopia's hyper-personalized approach combines the best of
human intervention and digital technology, along with genetic
engagement, to support improved health outcomes and reduced costs
for employers, health plans, ACOs and other risk-bearing
entities. With Newtopia, participants are empowered to lose
weight, reduce blood sugar, manage blood pressure, and lower
triglycerides and cholesterol while improving their overall mental
health (including depression, anxiety, mood and overall energy) to
avoid future illness. In the words of one participant, "I no
longer have type 2 diabetes or take any medications to control my
blood sugar. My A1C is 5, my cholesterol is normal, and I've
lost 160lbs. Newtopia has changed my life for good."
"This recognition by the CDC is very gratifying considering type
2 diabetes continues to be a major burden of illness for 1 in 3
adults who have prediabetes, and more than 1 in 10 living with type
2 diabetes," said Dr. Natasha Vani, VP Program Development
& Operations at Newtopia. "The key to Newtopia's success
lies in the engagement of our habit change program surpassing 75%
in the first year. High engagement and sustainable habit change is
what has allowed us to meet the strong retention criteria and
required outcomes defined by the CDC, earning us the extended
5-year status. It's no surprise that individuals in
Newtopia's program who have been diagnosed with type 2 diabetes see
a sustained 0.6% reduction in their average A1c, and 75% of severe
cases drop a full A1c level."
About Newtopia
Newtopia is a personalized whole health platform helping people
create positive lifelong habits that prevent, slow, or reverse
chronic disease while reducing healthcare costs. The platform
leverages genetic, social and behavioral insights to create
individualized prevention programs with a focus on metabolic
disease, diabetes, mental health challenges, hypertension, weight
management and musculoskeletal disorders. With a person-centered
approach that combines virtual care, digital tools, connected
devices and actionable data science, Newtopia delivers sustainable
clinical and financial outcomes. Newtopia serves some of the
largest nationwide employers and health plans and is currently
listed in Canada on the Toronto
Stock Exchange (TSXV: NEWU) and is quoted in the US on the
OTCQB® Venture Market (OTCQB: NEWUF). To learn more,
visit newtopia.com, LinkedIn or Twitter.
Forward Looking
Statements
This news release contains forward-looking
information and forward-looking statements, within the meaning of
applicable Canadian securities legislation, and forward looking
statements, within the meaning of applicable United States securities legislation
(collectively, "forward-looking statements"), which reflects
management's expectations regarding Newtopia's future growth,
results from operations (including, without limitation, future
production and capital expenditures), performance (both operational
and financial) and business prospects and opportunities. Wherever
possible, words such as "predicts", "projects", "targets", "plans",
"expects", "does not expect", "budget", "scheduled", "estimates",
"forecasts", "anticipate" or "does not anticipate", "believe",
"intend" and similar expressions or statements that certain
actions, events or results "may", "could", "would", "might" or
"will" be taken, occur or be achieved, or the negative or
grammatical variation thereof or other variations thereof, or
comparable terminology have been used to identify forward-looking
statements. All statements other than statements of historical fact
may be forward- looking information. Such statements reflect
Newtopia's current views and intentions with respect to
future events, based on information available to Newtopia, and
are subject to certain risks, uncertainties, and assumptions.
Material factors or assumptions were applied in providing
forward-looking information. While forward-looking statements
are based on data, assumptions and analyses that Newtopia believes
are reasonable under the circumstances, whether actual
results, performance or developments will meet Newtopia's
expectations and predictions depends on a number of risks and
uncertainties that could cause the actual results,
performance and financial condition of Newtopia
to differ materially from its expectations. Forward-looking
statements are not a guarantee and are based on a number of
estimates and assumptions management believes to be relevant and
reasonable, whether actual results, performance or developments
will meet Newtopia's expectations and predictions depends on
a number of risks and uncertainties that could cause the
actual results, performance and financial condition of
Newtopia to differ materially from its expectations. Certain of the
"risk factors" that could cause actual results to differ materially
from Newtopia's forward-looking statements in this press release
include, without limitation: the termination of contracts by
clients, risks related to COVID-19 including various
recommendations, orders and measures of governmental authorities to
try to limit the pandemic, including travel restrictions, border
closures, non-essential business closures, quarantines,
self-isolations, shelters- in-place and social distancing,
disruptions to markets, economic activity, financing, supply chains
and sales channels, and a deterioration of general economic
conditions including a possible national or global recession; and
other general economic, market and business conditions and factors,
including the risk factors discussed or referred to in Newtopia's
disclosure documents, filed with the securities
regulatory authorities in certain provinces of Canada and available at
www.sedar.com including Newtopia's final
long form prospectus
dated March 30, 2020.
Should any factor affect Newtopia's in an unexpected manner, or
should assumptions underlying the forward- looking information
prove incorrect, the actual results or events may differ materially
from the results or events predicted. Any such forward-looking
information is expressly qualified in its entirety by this
cautionary statement. Moreover, Newtopia does not assume
responsibility for the accuracy or completeness of such
forward-looking information. The forward-looking information
included in this press release is made as of the date of this press
release, and Newtopia undertakes no obligation to publicly update
or revise any forward-looking information, other than as required
by applicable law.
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/newtopia-earns-5-year-recognition-by-cdc-for-delivery-of-highest-quality-evidence-based-alternative-diabetes-prevention-program-301627296.html
SOURCE Newtopia Inc.